Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.500
-0.020 (-0.44%)
At close: Nov 21, 2024, 4:00 PM
4.510
+0.010 (0.22%)
After-hours: Nov 21, 2024, 4:26 PM EST
Sagimet Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 144 | 124 | - | - | - | - |
Enterprise Value | -26 | 22 | - | - | - | - |
Last Close Price | 4.52 | 5.42 | - | - | - | - |
PS Ratio | - | 62.05 | - | - | - | - |
PB Ratio | 0.85 | 1.36 | - | - | - | - |
P/TBV Ratio | 0.52 | 1.36 | - | - | - | - |
EV/Sales Ratio | - | 11.18 | - | - | - | - |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.04 |
Asset Turnover | - | 0.03 | - | - | - | - |
Quick Ratio | 37.26 | 16.78 | 6.13 | 23.25 | 35.97 | 4.92 |
Current Ratio | 38.41 | 17.09 | 6.21 | 24.04 | 35.99 | 5.21 |
Return on Equity (ROE) | -27.94% | -46.95% | -72.58% | -39.63% | -29.98% | - |
Return on Assets (ROA) | -20.58% | -29.61% | -42.17% | -23.16% | -17.79% | - |
Return on Capital (ROIC) | -21.27% | -32.29% | -45.89% | -23.93% | -18.65% | - |
Earnings Yield | -26.12% | -22.46% | - | - | - | - |
FCF Yield | -26.80% | -19.15% | - | - | - | - |
Buyback Yield / Dilution | -527.36% | -5565.90% | -50.61% | -26.95% | - | - |
Total Shareholder Return | -527.36% | -5565.90% | -50.61% | -26.95% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.